Cancer symptom management system: the system development and feasibility evaluation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002096

Enrollment

324

Registered

2016-10-07

Start date

2015-12-17

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : Control group only receives symptom monitoring utilizing study-developed symptom management system. Experimental 1 group receives symptom monitoring and symptom report will be delivered to

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult (19 years or orlder) cancer patients who were diagnosed with stomach, breast, colorectal, or lung cancer Planned to start adjucant or palliative chemotherapy of at least 4 cycles (for pilot trial of the system, Adult cancer patients who were diagnosed with stomach, breast, colorectal, or lung cancer and receiving adjuvant or palliative cancer or any cycle). Licensed clinicians (MD or RN), currently working medical oncology or caring for oncology patients with at least 2 years of clinical experience in the field, and providing chemotherapy and manage symptoms.

Exclusion criteria

Exclusion criteria: Patients who receive chemotherapy accompanied with surgery or radiation therapy Patients who have cognitive or psychiatric problems which might hinder study participation

Design outcomes

Primary

Measure	Time frame
Effect in symptom management: changes in symptom severity	—

Secondary

Measure	Time frame
Validity and Reliability of symptom management system;Quality of life;Feasibility;Patient satisfaction	—

Countries

Korea, Republic of

Contacts

Public ContactJiyeon Lee

Chungnam National University

jiyeonest@hotmail.com+82-42-580-8320

Outcome results